Suppr超能文献

CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy.

作者信息

Kranz Lena M, Beck Jan D, Grunwitz Christian, Hotz Christian, Vormehr Mathias, Diken Mustafa

机构信息

a BioNTech RNA Pharmaceuticals GmbH , Mainz , Germany.

b TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH , Mainz , Germany.

出版信息

Hum Vaccin Immunother. 2017 Oct 3;13(10):2272-2279. doi: 10.1080/21645515.2017.1358327.

Abstract
摘要

相似文献

1
CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy.
Hum Vaccin Immunother. 2017 Oct 3;13(10):2272-2279. doi: 10.1080/21645515.2017.1358327.
3
Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
World J Gastroenterol. 2018 May 28;24(20):2137-2151. doi: 10.3748/wjg.v24.i20.2137.
4
Clinical development of immunotherapy for prostate cancer.
Int J Urol. 2017 Sep;24(9):675-680. doi: 10.1111/iju.13397. Epub 2017 Jun 21.
5
Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative Strategies.
Oncol Res Treat. 2018;41(5):266-271. doi: 10.1159/000488120. Epub 2018 Apr 20.
6
Let's fight cancer: let-7 is a tool to enhance antitumor immune responses.
Future Oncol. 2018 May;14(12):1141-1145. doi: 10.2217/fon-2018-0037. Epub 2018 Apr 23.
7
The current landscape of early drug development for patients with sarcoma in the immunotherapy era.
Future Oncol. 2018 May;14(12):1197-1211. doi: 10.2217/fon-2017-0565. Epub 2018 Apr 27.
8
Combinatorial Cancer Immunotherapies.
Adv Immunol. 2016;130:251-77. doi: 10.1016/bs.ai.2015.12.005. Epub 2016 Jan 12.
10
Women's cancer: Advancing molecular and immunotherapy.
Curr Probl Cancer. 2017 Jan-Feb;41(1):7. doi: 10.1016/j.currproblcancer.2017.02.004.

本文引用的文献

1
Immune checkpoints on innate lymphoid cells.
J Exp Med. 2017 Jun 5;214(6):1561-1563. doi: 10.1084/jem.20170763. Epub 2017 May 17.
2
Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect.
ACS Omega. 2017 Mar 31;2(3):937-945. doi: 10.1021/acsomega.6b00436. Epub 2017 Mar 16.
4
Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma.
J Clin Oncol. 2016 Dec;34(34):4102-4109. doi: 10.1200/JCO.2016.67.2477. Epub 2016 Oct 31.
5
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.
N Engl J Med. 2016 Nov 10;375(19):1856-1867. doi: 10.1056/NEJMoa1602252. Epub 2016 Oct 8.
6
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.
Lancet Oncol. 2016 Oct;17(10):1386-1395. doi: 10.1016/S1470-2045(16)30297-2. Epub 2016 Aug 27.
7
8
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.
N Engl J Med. 2016 Sep 1;375(9):819-29. doi: 10.1056/NEJMoa1604958. Epub 2016 Jul 13.
9
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.
Nature. 2016 Jun 16;534(7607):396-401. doi: 10.1038/nature18300. Epub 2016 Jun 1.
10
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires.
Science. 2016 Jun 10;352(6291):1337-41. doi: 10.1126/science.aaf2288. Epub 2016 May 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验